Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ErythroCure Logo
ErythroCure CB Rank
2449342
Heat Score
50
ErythroCure developing new therapeutics to treat congenital and acquired disorders of the blood.
Founded
obfuscation
Private West Lafayette, Indiana, United States1-10 erythrocure.com
Therapeutics
Overview

ErythroCure
Heat Score
50

Growth Score
pts
in past quarter
Heat Score 50
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ErythroCure

CB Rank
2449342
ErythroCure developing new therapeutics to treat congenital and acquired disorders of the blood.
Founded
obfuscation
Private West Lafayette, Indiana, United States1-10 erythrocure.com
Therapeutics

Key People

  • Photo of Philip Low
    Philip Low: Co-founder, Director and Chief Science Officer
    Past Role: Endocyte, Co-Founder, Chief Science Officer & Board Member

Details

Legal Name ErythroCure Inc.
Also Known As ErythroCure
Operating Status Active
Company Type For Profit
Founders  Philip Low
About the Company
ErythroCure endeavors to translate new treatment options into clinical practice by advancing lab-based discoveries in basic biology through the drug discovery and development pipeline
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Therapeutics for Congenital and Acquired Blood Disorders
Development of new treatments targeting congenital and acquired disorders of the blood, including blood cancers and blood-borne diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Active Website Tech Count

4ErythroCure is actively using 4 technologies for its website, according to BuiltWith. These include Euro, CommonCrawl Top 10m, and  GoDaddy Airo Placeholder.
Sub-Organizations
Frequently Asked Questions

Where is ErythroCure's headquarters? ErythroCure is located in West Lafayette, Indiana, United States.Who are ErythroCure's competitors? Alternatives and possible competitors to ErythroCure may include Siteman Cancer Center, UC San Diego Health Moores Cancer Center, and  Moores Cancer Center.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|